<DOC>
	<DOCNO>NCT00185848</DOCNO>
	<brief_summary>The purpose study determine whether [ 18F ] FHBG suitable use image probe cancer rheumatoid arthritis patient enrol cell gene therapy trial . In phase 1 study ass safety biodistribution [ 18F ] FHBG patient .</brief_summary>
	<brief_title>Assessing Suitability Imaging Probe Use Clinical Cell Gene Therapy Trials Cancer Rheumatoid Arthritis</brief_title>
	<detailed_description>The success cell gene therapy depend specific target therapeutic gene cell administer patient . Our goal develop image method non-invasively monitor location therapeutic gene cell . Imaging help design well protocol potentially reduce side-effects cell gene therapy .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<criteria>Clinical diagnosis brain tumor rheumatoid arthritis Below 18 year age</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>